Ignite Creation Date:
2024-05-06 @ 9:58 AM
Last Modification Date:
2024-10-26 @ 12:22 PM
Study NCT ID:
NCT03128710
Status:
COMPLETED
Last Update Posted:
2020-11-03
First Post:
2017-04-19
Brief Title:
Prostate Cancer Survey
Sponsor:
University of Maryland Baltimore
Organization:
University of Maryland Baltimore
Study Overview
Official Title:
Identifying Patient-relevant Adverse Events Following Prostate Radiotherapy
Status:
COMPLETED
Status Verified Date:
2020-11
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
There have been calls from patients payers healthcare providers and policy makers for an evaluation of newer high-cost radiation technologies compared to conventional forms of radiation therapy National attention has focused on the use of intensity modulated radiation therapy IMRT into routine daily clinical practice for prostate cancer The goal of the present study is to determine whether the type of radiation treatment received by the patients can result in a reduction in patient-relevant side effects following prostate irradiation The analysis will be performed by obtaining patient answered surveys looking at side effects
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None